| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Characterization of Myeloid-derived Suppressor Cells in a Patient With Lung Adenocarcinoma Undergoing Durvalumab Treatment: A Case Report
|
Bertelli, Giacomo
|
|
2019
|
20 |
4 |
p. e514-e516
|
artikel
|
| 2 |
Chemotherapy and Radiation Versus Chemotherapy Alone for Elderly Patients With N3 Stage IIIB NSCLC
|
Qin, Angel
|
|
2019
|
20 |
4 |
p. e495-e503
|
artikel
|
| 3 |
Chemotherapy Versus Supportive Care for Unresected Malignant Pleural Mesothelioma
|
Verma, Vivek
|
|
2019
|
20 |
4 |
p. 263-269
|
artikel
|
| 4 |
Clinical and Prognostic Significance of the Epithelial–Mesenchymal Transition in Stage IA Lung Adenocarcinoma: A Propensity Score–Matched Analysis
|
Matsubara, Taichi
|
|
2019
|
20 |
4 |
p. e504-e513
|
artikel
|
| 5 |
Concomitant EGFR Mutation and EML4-ALK Rearrangement in Lung Adenocarcinoma Is More Frequent in Multifocal Lesions
|
Fan, Jun
|
|
2019
|
20 |
4 |
p. e517-e530
|
artikel
|
| 6 |
Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients
|
Cortellini, Alessio
|
|
2019
|
20 |
4 |
p. 237-247.e1
|
artikel
|
| 7 |
Editorial Board
|
|
|
2019
|
20 |
4 |
p. A2
|
artikel
|
| 8 |
Efficacy and Safety of BRAF Inhibitors With or Without MEK Inhibitors in BRAF-Mutant Advanced Non–Small-Cell Lung Cancer: Findings From a Real-Life Cohort
|
Dudnik, Elizabeth
|
|
2019
|
20 |
4 |
p. 278-286.e1
|
artikel
|
| 9 |
Financial Burden Among Patients With Lung Cancer in a Publically Funded Health Care System
|
Ezeife, Doreen A.
|
|
2019
|
20 |
4 |
p. 231-236
|
artikel
|
| 10 |
Heterogeneous Expression of Programmed Death Receptor-ligand 1 on Circulating Tumor Cells in Patients With Lung Cancer
|
Koh, Yasuhiro
|
|
2019
|
20 |
4 |
p. 270-277.e1
|
artikel
|
| 11 |
Immune Checkpoint Inhibitor-Induced Myasthenia Gravis in a Patient with Advanced NSCLC and Remote History of Thymoma
|
Lara, Matthew S.
|
|
2019
|
20 |
4 |
p. e489-e491
|
artikel
|
| 12 |
Impact of Corticosteroid Administration on Outcomes Following Stereotactic Ablative Radiotherapy for Non–small-cell Lung Cancer
|
Li, Hongqi
|
|
2019
|
20 |
4 |
p. e480-e488
|
artikel
|
| 13 |
Indoor Radon in EGFR- and BRAF-Mutated and ALK-Rearranged Non–Small-Cell Lung Cancer Patients
|
Mezquita, Laura
|
|
2019
|
20 |
4 |
p. 305-312.e3
|
artikel
|
| 14 |
Next-generation Sequencing for ALK and ROS1 Rearrangement Detection in Patients With Non–small-cell Lung Cancer: Implications of FISH-positive Patterns
|
Clavé, Sergi
|
|
2019
|
20 |
4 |
p. e421-e429
|
artikel
|
| 15 |
Node-Positive Segmentectomy for Non–Small-Cell Lung Cancer: Risk Factors and Outcomes
|
Lutfi, Waseem
|
|
2019
|
20 |
4 |
p. e463-e469
|
artikel
|
| 16 |
Patterns of Care and Survival in Stage III NSCLC Among Black and Latino Patients Compared With White Patients
|
Vyfhuis, Melissa A.L.
|
|
2019
|
20 |
4 |
p. 248-257.e4
|
artikel
|
| 17 |
Pemetrexed in the Treatment of Leptomeningeal Metastasis in Patients With EGFR-mutant Lung Cancer
|
Choi, Mihong
|
|
2019
|
20 |
4 |
p. e442-e451
|
artikel
|
| 18 |
Phase I/II Study of Osimertinib With Bevacizumab in EGFR-mutated, T790M-positive Patients With Progressed EGFR-TKIs: West Japan Oncology Group 8715L (WJOG8715L)
|
Akamatsu, Hiroaki
|
|
2019
|
20 |
4 |
p. e492-e494
|
artikel
|
| 19 |
Predictors of Outcomes and a Scoring System for Estimating Survival in Patients Treated With Radiotherapy for Metastatic Spinal Cord Compression From Small-Cell Lung Cancer
|
Rades, Dirk
|
|
2019
|
20 |
4 |
p. 322-329
|
artikel
|
| 20 |
Programmed Cell Death Ligand 1 Immunohistochemistry: A Concordance Study Between Surgical Specimen, Biopsy, and Tissue Microarray
|
Elfving, Hedvig
|
|
2019
|
20 |
4 |
p. 258-262.e1
|
artikel
|
| 21 |
Real-World Clinical Impact of Immune Checkpoint Inhibitors in Patients With Advanced/Metastatic Non–Small Cell Lung Cancer After Platinum Chemotherapy
|
Schwartzberg, Lee
|
|
2019
|
20 |
4 |
p. 287-296.e4
|
artikel
|
| 22 |
Relationship Between Prior Radiotherapy and Checkpoint-Inhibitor Pneumonitis in Patients With Advanced Non–Small-Cell Lung Cancer
|
Voong, Khinh Ranh
|
|
2019
|
20 |
4 |
p. e470-e479
|
artikel
|
| 23 |
Relevance of Detection of Mechanisms of Resistance to ALK Inhibitors in ALK-Rearranged NSCLC in Routine Practice
|
Jamme, Philippe
|
|
2019
|
20 |
4 |
p. 297-304.e1
|
artikel
|
| 24 |
Response to First-Line Osimertinib Treatment in Non–Small-Cell Lung Cancer With Coexisting G719A and Primary T790M Epidermal Growth Factor Receptor Mutations
|
Ikari, Tomoo
|
|
2019
|
20 |
4 |
p. e531-e533
|
artikel
|
| 25 |
Small-cell Lung Cancer in Very Elderly (≥ 80 Years) Patients
|
Schild, Steven E.
|
|
2019
|
20 |
4 |
p. 313-321
|
artikel
|
| 26 |
Stereotactic Body Radiotherapy for Centrally Located Primary Non–Small-Cell Lung Cancer: A Meta-Analysis
|
Yu, Tosol
|
|
2019
|
20 |
4 |
p. e452-e462
|
artikel
|
| 27 |
Table of Contents
|
|
|
2019
|
20 |
4 |
p. A3, A13-A14, A16, A17
|
artikel
|
| 28 |
Thoracic Oncology Multidisciplinary Clinic Reduces Unnecessary Health Care Expenditure Used in the Workup of Patients With Non–small-cell Lung Cancer
|
Voong, Khinh Ranh
|
|
2019
|
20 |
4 |
p. e430-e441
|
artikel
|
Tijdschrift beschrijving